cancer-cell
Cancer Cell (cancer-cell)
Journal positioning
Cancer Cell is Cell Press's flagship cancer-biology journal, publishing mechanistic studies that illuminate how tumors initiate, progress, resist therapy, or interact with the immune microenvironment — and that carry explicit translational or clinical relevance. The readership spans cancer biologists, oncologists, and physician-scientists, so a paper must deliver both mechanistic depth and a clear statement of why the finding matters for cancer biology or patient care. Descriptive oncology, biomarker discovery without mechanism, or purely clinical trial reporting do not belong here.
This skill is a fit / venue-selection / re-framing tool. It does not replace the journal's current official submission guidelines. Before submitting, re-check the live author instructions on the Cell Press site or submission system.
When to trigger
- The author names Cancer Cell as the target venue.
- A mechanistic cancer study asks whether its translational framing and evidence depth meet the bar.
- A manuscript sits between Cancer Cell and Cancer Discovery, Nature Cancer, or Cell and the author needs to differentiate.
- The author needs Cancer Cell's most common desk-reject patterns and credible re-routing options.